Neuberger Berman Group Portfolio holdings
AUM
$130B
1-Year Return
22.03%
This Quarter Return
-3.68%
1 Year Return
+22.03%
3 Year Return
+86.29%
5 Year Return
+159.6%
10 Year Return
+388.21%
AUM
$118B
AUM Growth
-$9.43B
(-7.4%)
Cap. Flow
-$3.82B
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
14.37%
Holding
2,014
New
115
Increased
767
Reduced
912
Closed
116
Top Buys
| 1 |
S&P Global
SPGI
|
+$464M |
| 2 |
Apollo Global Management
APO
|
+$274M |
| 3 |
Zimmer Biomet
ZBH
|
+$185M |
| 4 |
Baxter International
BAX
|
+$122M |
| 5 |
Costco
COST
|
+$116M |
Top Sells
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$500M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$310M |
| 3 |
Apple
AAPL
|
+$235M |
| 4 |
CCMP
CMC Materials, Inc. Common Stock
CCMP
|
+$211M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$194M |
Sector Composition
| 1 | Technology | 25.4% |
| 2 | Financials | 14.5% |
| 3 | Healthcare | 11.24% |
| 4 | Industrials | 11.03% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNR
1326
Core Natural Resources, Inc.
CNR
$3.74B
| $1.05M | ﹤0.01% |
27,776
+8
| +0% | +$301 |
|
1327
Alnylam Pharmaceuticals
ALNY
$61.5B
| $1.03M | ﹤0.01% |
6,285
+2,584
| +70% | +$422K |
|
1328
Principal Financial Group
PFG
$17.8B
| $1.02M | ﹤0.01% |
13,673
-2,465
| -15% | -$184K |
|
1329
Middleby
MIDD
$6.99B
| $1.01M | ﹤0.01% |
6,167
+1,016
| +20% | +$167K |
|
1330
British American Tobacco
BTI
$123B
| $1.01M | ﹤0.01% |
23,925
+4,196
| +21% | +$177K |
|
1331
Henry Schein
HSIC
$8.17B
| $1.01M | ﹤0.01% |
11,564
-230
| -2% | -$20.1K |
|
1332
Encompass Health
EHC
$12.6B
| $1.01M | ﹤0.01% |
17,808
+385
| +2% | +$21.8K |
|
1333
F5
FFIV
$18.8B
| $1M | ﹤0.01% |
4,789
-17
| -0.4% | -$3.55K |
|
1334
Idacorp
IDA
$6.76B
| $999K | ﹤0.01% |
8,662
+1,550
| +22% | +$179K |
|
1335
iShares MSCI Saudi Arabia ETF
KSA
$559M
| $997K | ﹤0.01% |
21,000
+1,400
| +7% | +$66.5K |
|
1336
Vanguard Energy ETF
VDE
$7.34B
| $997K | ﹤0.01% |
9,309
+56
| +0.6% | +$6K |
|
1337
nCino
NCNO
$3.47B
| $984K | ﹤0.01% |
24,008
-1,383
| -5% | -$56.7K |
|
1338
Booz Allen Hamilton
BAH
$12.6B
| $976K | ﹤0.01% |
11,006
-269
| -2% | -$23.9K |
|
1339
Lyft
LYFT
$7.87B
| $973K | ﹤0.01% |
25,343
+5,602
| +28% | +$215K |
|
1340
Xylem
XYL
$33.5B
| $973K | ﹤0.01% |
11,409
+3,781
| +50% | +$322K |
|
|
FAZE
1341
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $967K | ﹤0.01% |
97,433
-1,348
| -1% | -$13.4K |
|
1342
Tootsie Roll Industries
TR
$2.88B
| $966K | ﹤0.01% |
30,189
+17,975
| +147% | +$575K |
|
|
CLR
1343
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $963K | ﹤0.01% |
15,710
-974
| -6% | -$59.7K |
|
1344
Levi Strauss
LEVI
$8.59B
| $957K | ﹤0.01% |
48,440
+33,429
| +223% | +$660K |
|
1345
Journey Medical
DERM
$190M
| $955K | ﹤0.01% |
197,637
-1,475
| -0.7% | -$7.13K |
|
1346
Sanofi
SNY
$115B
| $955K | ﹤0.01% |
18,600
+2,438
| +15% | +$125K |
|
1347
SPDR S&P Dividend ETF
SDY
$20.3B
| $948K | ﹤0.01% |
7,395
-2,640
| -26% | -$338K |
|
|
CTO
1348
CTO Realty Growth
CTO
$561M
| $947K | ﹤0.01% |
42,822
| – | – |
|
|
FZT
1349
DELISTED
FAST Acquisition Corp. II
FZT
| $941K | ﹤0.01% |
96,550
-33,295
| -26% | -$325K |
|
1350
Waters Corp
WAT
$17.4B
| $939K | ﹤0.01% |
3,027
+763
| +34% | +$237K |
|